For many ASX investors, much of their excitement of the stock market comes from picking a winning growth share and (hopefully) watching it do its thing.
But have ASX growth shares had their moment? One expert is going against the grain to declare the time has come to turn away from growth shares and towards more established investments.
Are they right? Here are some arguments for and against investing in growth shares in 2022.
ASX growth shares: the bulls and the bears
Epoch Global Equity Shareholder Yield portfolio manager, John Tobin has come out swinging against growth shares today. He believes they will suffer in a rising interest rates environment.
According to Tobin, growth stocks have been outperforming established shares since 2020 due to a period of “artificially low interest rates”.
“Our argument is [growth stocks] are going to face stronger headwinds when rates rise,” he said.
“It’s about the math, you can’t get around it … for a given increase in interest rates, the impact on present value is greater for cash flows in the distant future.”
However, other experts counter Tobin’s bearish outlook with their own bullish arguments.
Montgomery Investment Management chair and chief investment officer, Roger Montgomery claims the pull-back experienced by the S&P/ASX 200 Index (ASX: XJO) in 2022 has left many growth shares trading for bargain prices.
In a piece published to Livewire, Montgomery said, “the current equity correction has taken a lot of the froth out of the market.
“But caught up in the carnage have been a number of high-quality companies with years of growth ahead.”
Among them, are tech shares Megaport Ltd (ASX: MP1) and Pro Medicus Limited (ASX: PME). Each has had their price-to-earnings (P/E) ratios fall between 31% and 33% since the start of 2022, according to the expert.
Meanwhile, those of Transurban Group (ASX: TCL) and Reece Ltd (ASX: REH) have fallen between 25% and 29%.
Montgomery says now is the time to get in on “some of the highest quality names in the market”. He continued:
This is … a plain vanilla correction that will see investors who have taken on too much risk in the quest for returns suffer more than those who have been disciplined about quality and value.
The post Are ASX growth shares still worth holding in 2022? appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- 2 quality ASX 200 tech shares with ‘years of growth’ ahead: broker
- Goldman Sachs names 2 ASX 200 shares with major upside potential
- 2 ASX tech shares we’re backing through the turmoil: analysts
- 2 top ASX growth shares that are worth buying: brokers
- How did ASX tech shares perform today?
Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended MEGAPORT FPO and Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended MEGAPORT FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/8FTi9tr
Leave a Reply